Decrease of current responses at human recombinant P2X3 receptors after substitution by Asp of Ser/Thr residues in protein kinase C phosphorylation sites of their ecto-domains

Neurosci Lett. 2006 Jan 23;393(1):78-83. doi: 10.1016/j.neulet.2005.09.045. Epub 2005 Oct 13.

Abstract

The whole-cell patch-clamp technique was used to record current responses to nucleotides in HEK 293 cells transiently transfected with the human (h) P2X(3) receptor. When GDP-beta-S was included into the pipette solution, UTP at concentrations which did not alter the holding current, facilitated the alpha,beta-methylene ATP (alpha,beta-meATP)-induced current. The substitution of Ser/Thr residues situated within protein kinase C (PKC) consensus phosphorylation sites of the P2X(3) receptor ecto-domain by the neutral amino acid Ala either abolished (T134A, S178A) or did not alter (T196A, S269A) the UTP-induced potentiation of the alpha,beta-meATP current. The substitution of the same Ser/Thr residues in all four PKC sites by the negatively charged Asp prevented the potentiation by UTP. The Asp mutations abolished the first, fast offset time-constant, but did not alter, or in the case of S269D even increased, the second, slow offset time-constant; at the same time such mutations invariably increased the onset time-constant and massively depressed the peak current amplitude. None of the Ala mutations (with the exception of S269A) influenced the time-course of desensitisation or the peak current amplitude. It is concluded that constitutive activation of PKC sites at the ecto-domain of the hP2X(3) receptor both abolishes the UTP-induced potentiation of the alpha,beta-meATP current and accelerates its rate of desensitisation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / analogs & derivatives
  • Adenosine Triphosphate / pharmacology
  • Aspartic Acid / genetics
  • Aspartic Acid / metabolism*
  • Cell Line
  • Dose-Response Relationship, Drug
  • Electric Stimulation / methods
  • Humans
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology*
  • Membrane Potentials / radiation effects
  • Mutagenesis / physiology
  • Patch-Clamp Techniques / methods
  • Phosphorylation
  • Protein Kinase C / chemistry
  • Protein Kinase C / metabolism*
  • Purinergic P2 Receptor Agonists
  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2 / physiology*
  • Receptors, Purinergic P2X2
  • Recombinant Proteins / metabolism
  • Serine / genetics
  • Serine / metabolism*
  • Threonine / metabolism*
  • Transfection / methods
  • Uridine Triphosphate / pharmacology

Substances

  • P2RX2 protein, human
  • Purinergic P2 Receptor Agonists
  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2X2
  • Recombinant Proteins
  • Threonine
  • Aspartic Acid
  • Serine
  • Adenosine Triphosphate
  • Protein Kinase C
  • alpha,beta-methyleneadenosine 5'-triphosphate
  • Uridine Triphosphate